The latest announcement is out from Cyclerion Therapeutics (CYCN).
Regina Graul, Ph.D., has been promoted to Chief Executive Officer, as announced in a recent press release by the Company on August 7, 2024. The details of this corporate leadership update, which reflect significant news for investors and market watchers, can be accessed through the Company’s website, although it’s clarified that this information isn’t intended for formal filing purposes under certain sections of the Securities Exchange Act.
Find detailed analytics on CYCN stock on TipRanks’ Stock Analysis page.
